tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Laura Sutcliffe, 31 are a BUY (44.29%), 39 are a HOLD (55.71%).
Analyst Laura Sutcliffe, currently employed at CITI, carries an average stock price target met ratio of 49.44% that have a potential upside of 30.71% achieved within 583 days.
Laura Sutcliffe’s has documented 134 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TLX, Telix Pharmaceuticals at 07-Jul-2026.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Oct-2020
$33
$4.87 (17.31%)
$32
4 months 16 days ago
(25-Feb-2026)
17/19 (89.47%)
$-1.02 (-3.00%)
59
Hold Since 09-Sep-2024
$40
$11.87 (42.20%)
$24
8 months 20 days ago
(21-Oct-2025)
1/2 (50%)
$8.57 (27.27%)
127
Hold Since 07-Mar-2024
$22
$-6.13 (-21.79%)
$31
1 years 4 months 27 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Hold Since 13-Oct-2020
$82.77
1 years 5 months 18 days ago
(23-Jan-2025)
2/6 (33.33%)
$-1.59 (-1.88%)
32
Hold Since 14-Oct-2022
1 years 5 months 18 days ago
(23-Jan-2025)
1/5 (20%)
$2.78 (6.01%)
43
Which stock is Laura Sutcliffe is most bullish on?
Which stock is Laura Sutcliffe is most reserved on?
What Year was the first public recommendation made by Laura Sutcliffe?
